enGene Holdings Inc. Common Stock

ENGN

enGene Holdings Inc. is a biopharmaceutical company focused on developing gene-based therapies. It specializes in leveraging genomic technology to create treatments for various medical conditions, aiming to advance precision medicine solutions through its innovative research and clinical development efforts.

$8.06 -0.01 (-0.06%)
Dividend Yield 19.74%
Payout Frequency Monthly

Dividend History

Pay DateAmountEx-DateRecord Date
August 7, 2015$0.132015-08-032015-08-05
July 8, 2015$0.132015-07-012015-07-06
June 5, 2015$0.132015-06-012015-06-03
May 7, 2015$0.122015-05-012015-05-05
April 8, 2015$0.132015-04-012015-04-06

Dividends Summary

Company News

Why AppLovin Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Benzinga • Avi Kapoor • February 15, 2024

Shares of AppLovin Corporation (NASDAQ: APP) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results. AppLovin reported quarterly earnings of 49 cents per share which beat the analyst consensus estimate of 36 cents. The company reported quarterly sales of $953.26 million, beat...

Related Companies